Intrinsic Value of S&P & Nasdaq Contact Us

Celcuity Inc. CELC NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
36/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$108.75
-10%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Celcuity Inc. (CELC) has a negative trailing P/E of -35.0, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 32.2 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -2.86%, forward earnings yield 3.11%. PEG 0.50 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (57/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
  • Forward P/E 32.2 — analysts expect a return to profitability with estimated EPS of $3.76 for FY2028.
  • PEG Ratio 0.50 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -2.86% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 3.11% as earnings recover.
  • Analyst consensus target $108.75 (-10% downside) — slight downside risk — the market may be ahead of analyst expectations.

Overall SharesGrow Score: 34/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
36/100
SG Score
View full scorecard →
~
VALUE
57/100
Price-to-Earnings & upside
Proven by this page
FUTURE
68/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
MOAT
40/100
→ Income
GROWTH
15/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — CELC

Valuation Multiples
P/E (TTM)-35.0
Forward P/E32.2
PEG Ratio0.50
Forward PEG0.50
P/B Ratio61.56
P/S Ratio0.00
EV/EBITDA-37.8
Per Share Data
EPS (TTM)$-3.37
Forward EPS (Est.)$3.76
Book Value / Share$1.91
Revenue / Share$0.00
FCF / Share$-2.92
Yields & Fair Value
Earnings Yield-2.86%
Forward Earnings Yield3.11%
Dividend Yield0.00%
Analyst Target$108.75 (-10%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -29.0 -0.80 17.11 0.00 -
2017 -22.6 -0.32 4.50 0.00 -
2018 -32.5 2.73 9.58 0.00 -
2019 -14.8 2.19 5.64 0.00 -
2020 -9.9 -0.34 8.04 0.00 -
2021 -6.0 -0.04 2.57 0.00 -
2022 -5.4 -0.30 1.61 0.00 -
2023 -5.4 -14.50 2.47 0.00 -
2024 -4.6 -0.89 4.47 0.00 -
2025 -29.6 -0.88 52.11 0.00 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-0.49 $0.00 $-3.31M -
2017 $-0.84 $0.00 $-6.25M -
2018 $-0.74 $0.00 $-7.48M -
2019 $-0.69 $0.00 $-7.02M -
2020 $-0.89 $0.00 $-9.09M -
2021 $-2.28 $0.00 $-30.56M -
2022 $-2.68 $0.00 $-41.35M -
2023 $-2.69 $0.00 $-63.78M -
2024 $-2.83 $0.00 $-111.78M -
2025 $-3.78 $0.00 $-177.04M -

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-3.91 $-4.96 – $-3.14 $56.73M $43.83M – $65.31M 5
2027 $-0.15 $-0.69 – $0.25 $366.17M $263.16M – $523.87M 4
2028 $3.76 $1.93 – $5.65 $707.17M $707.15M – $707.2M 6
2029 $7.44 $3.47 – $12.86 $1.05B $620.34M – $1.64B 4
2030 $10.16 $4.74 – $17.57 $1.42B $836.87M – $2.21B 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message